Mirae Asset Global Investments Co. Ltd. Boosts Holdings in Cigna Group $CI

Mirae Asset Global Investments Co. Ltd. grew its position in Cigna Group (NYSE:CI) by 11.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 45,235 shares of the health services provider’s stock after acquiring an additional 4,738 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Cigna Group were worth $13,039,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in CI. Pathway Financial Advisers LLC raised its holdings in shares of Cigna Group by 2.3% in the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after buying an additional 34 shares during the period. Armstrong Advisory Group Inc. grew its position in Cigna Group by 17.7% in the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after acquiring an additional 34 shares during the last quarter. HM Payson & Co. increased its stake in Cigna Group by 0.9% in the third quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after purchasing an additional 35 shares during the period. Carr Financial Group Corp boosted its stake in shares of Cigna Group by 5.3% during the third quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock valued at $204,000 after purchasing an additional 36 shares during the period. Finally, Natural Investments LLC boosted its stake in shares of Cigna Group by 2.0% during the third quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock valued at $531,000 after purchasing an additional 36 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on CI. TD Cowen set a $333.00 price target on shares of Cigna Group in a research note on Monday, December 15th. UBS Group set a $294.00 target price on Cigna Group in a report on Wednesday, November 12th. Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd. Truist Financial upped their price objective on shares of Cigna Group from $310.00 to $320.00 and gave the stock a “buy” rating in a research note on Monday, January 5th. Finally, Wells Fargo & Company dropped their target price on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and an average target price of $323.84.

Cigna Group Trading Up 0.9%

NYSE CI opened at $273.69 on Friday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a 50 day moving average price of $274.57 and a 200 day moving average price of $284.65. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. The firm has a market cap of $73.11 billion, a PE ratio of 12.07, a price-to-earnings-growth ratio of 0.96 and a beta of 0.26.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. The business had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The business’s quarterly revenue was up 9.5% on a year-over-year basis. During the same period in the prior year, the firm posted $7.51 earnings per share. As a group, sell-side analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani purchased 4,134 shares of the stock in a transaction on Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the acquisition, the chief executive officer owned 157,935 shares in the company, valued at $38,201,317.80. The trade was a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. 0.70% of the stock is owned by corporate insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.